WaveMan · Form 4
Heron Patrick J insider trades
> Search tickers & screens ⌘K
LIVE

Heron Patrick J insider trades

Heron Patrick J has filed 37 Form 4s with the SEC that we hold, for Mirum Pharmaceuticals, Inc. (MIRM) (Director), Arcutis Biotherapeutics, Inc. (ARQT) (Director), HLVX (Director) and MBX Biosciences, Inc. (MBX) (Director, 10% owner), among 5 companies in all. Across all of them we count 29 purchases worth $24.2M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($9.0M) and 0 sales ($0). The largest single trade was a purchase of 625,000 shares of MBX Biosciences, Inc. worth $10.0M, dated 2024-09-16. The first filing on our record is dated 2021-07-19 and the latest 2026-06-17.

Mirum Pharmaceuticals, Inc. (MIRM)

Director · 16 filings · 18 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-08-31P, purchase reported on Form 4147,991$3.9M2023-09-05
2023-09-11P, purchase reported on Form 44,687$142.0K2023-09-13
2023-09-12P, purchase reported on Form 43,750$114.8K2023-09-13
2023-09-13P, purchase reported on Form 42,625$81.4K2023-09-15
2023-11-09P, purchase reported on Form 42,910$82.4K2023-11-14
2024-09-06P, purchase reported on Form 4230$9.6K2024-09-10
2024-09-18P, purchase reported on Form 4115$4.3K2024-09-20
2025-03-04P, purchase reported on Form 41,279$58.3K2025-03-06
2025-03-04P, purchase reported on Form 456$2.6K2025-03-06
2025-03-05P, purchase reported on Form 4267$11.9K2025-03-06
2025-03-06P, purchase reported on Form 41,335$58.6K2025-03-10
2025-03-07P, purchase reported on Form 4580$25.1K2025-03-10
2025-03-10P, purchase reported on Form 4577$25.0K2025-03-12
2025-03-10P, purchase reported on Form 4758$32.3K2025-03-12
2025-03-11P, purchase reported on Form 4963$42.2K2025-03-12
2025-03-14P, purchase reported on Form 4528$23.3K2025-03-18
2025-03-17P, purchase reported on Form 421$9232025-03-18
2026-01-23P, purchase reported on Form 4131,425$9.0M2026-01-27

Arcutis Biotherapeutics, Inc. (ARQT)

Director · 12 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-03-04P, purchase reported on Form 421,052$200.0K2024-03-06
2025-05-09P, purchase reported on Form 46,300$85.7K2025-05-13
2025-05-13P, purchase reported on Form 42,374$32.7K2025-05-15
2025-05-14P, purchase reported on Form 46,300$86.7K2025-05-15
2025-05-15P, purchase reported on Form 42,520$34.3K2025-05-19
2025-05-21P, purchase reported on Form 42,520$34.4K2025-05-23
2025-05-22P, purchase reported on Form 42,520$34.4K2025-05-23
2025-06-04P, purchase reported on Form 41,890$25.2K2025-06-06
2025-06-05P, purchase reported on Form 4378$5.1K2025-06-06
2025-06-13P, purchase reported on Form 42,646$34.6K2025-06-17

HLVX

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

MBX Biosciences, Inc. (MBX)

Director, 10% owner · 4 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-09-16P, purchase reported on Form 4625,000$10.0M2024-09-17

IMGO

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1365617) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms